COVID-19

May 5, 2020

ACE inhibitors and ARBS not linked to COVID-19 infection or severity | Effective treatment of severe COVID-19 patients with tocilizumab | Insight into FDA’s Revised Policy on Antibody Tests: Prioritizing Access and Accuracy

April 30, 2020

Pulmonary Embolism and Increased Levels of d-Dimer in Patients with Coronavirus Disease | Adaptive COVID-19 Treatment Trial “ACTT” (NIAID) | SIMPLE I Trial results (Gilead) | Remdesivir in Chinese adults with severe COVID-19

April 28, 2020

Estimation of SARS-CoV-2 infection fatality rate by real-time antibody screening of blood donors | Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2 | Human leukocyte antigen susceptibility map for SARS-CoV-2

April 24, 2020

The Recovery Trial is a multi-arm multi-stage adaptive trial with mortality as the primary endpoint together with a 10 year follow up period linked to the electronic health records of ~6900 Covid-19 patients in the UK enrolled to date treated with either: placebo or ritonavir/lopinavir or steroids or azithromycin or hydroxy-chloroquine.

April 22, 2020

COVID-19 treatment guidelines – The COVID-19 Treatment Guidelines Panel (the Panel) does not recommend the use of any agents for pre-exposure prophylaxis (PrEP) against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outside of the setting of a clinical trial. | Human leukocyte antigen susceptibility map for SARS-CoV-2

April 20, 2020

COVID-19 Lung Injury is Not High Altitude Pulmonary Edema | Factors associated with hospitalization and critical illness among 4,103 patients with COVID-19 disease in New York City | Hydroxychloroquine in patients with COVID-19: an open-label, randomized, controlled trial

April 13, 2020

Pulmonary and Cardiac Pathology in Covid-19: The First Autopsy Series from New Orleans
Authors report on the relevant cardiopulmonary findings in the first series of autopsies in the United States, with the cause of death being due to SARS-CoV-2 infection. These cases identify key pathologic states potentially contributing to severe disease and decompensation in these patients.

April 8, 2020

Co-detection of respiratory pathogens in patients hospitalized with Coronavirus | Loss of smell and taste in combination with other symptoms is a strong predictor of COVID-19 infection

April 5, 2020

Tiger at New York’s Bronx Zoo Tests Positive for Coronavirus | Use of Hydroxychloroquine and Chloroquine During the COVID-19 Pandemic: What Every Clinician Should Know

April 1, 2020

Virological assessment of hospitalized patients with COVID-2019 | Efficacy of hydroxychloroquine in patients with COVID-19: results of a randomized clinical trial | Control the Contagion – Videos about the SARS-CoV-2 outbreak filmed by actors of Contagion

Parasites Without Borders

A comprehensive educational resource on all aspects of parasitic diseases and their impact on humanity around the globe.

Donate to Parasites Without Borders today!

Help bring the latest medical and basic biological information pertaining to diseases caused by eukaryotic parasites to every practicing physician and medical student within the United States. 

Scroll to Top